RUBY BIO INC
Proprietary yeast-based biosynthesis platform that converts sugar into biodegradable, non-toxic specialty chemicals
- Sector
- Biotech
- Headquarters
- SAN CARLOS, CA
- Founded
- 2022
- Latest Form D
- $8M, Jun 2025
- Total capital
- $8.9M
- Federal grants
- $158K
- 1 award · 2025
- Rank in peer group#382 of 392
- Private capital raised
- $8.8M
- 2 Form D · last Jun 2025
- 17 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 25 pending
Capital timeline
Latest events
- Federal grantAgriculture · Surfactants Are A Category Of Chemicals That Performs Cleaning, Shelf-life Stability, And Enhances Texture. These Essential Chemicals Are Widely Used To Power Consumer And Household Products, From Laundry Detergents, Liquid Soap, And Shampoo, To Paints And Food Ingredients. They Are Also Used In A Broad Range Of Industrial Applications Such As Coatings, Adhesives, Lubricants, And Textile Processing, As Well As Agricultural Crop Protection And Pest Control. 20 Million Tons Of Surfactant Are Produ$158K
- Private capital raisedForm D · SEC · 2nd filing$8M
- Private capital raisedForm D · SEC · 1st filing$800K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 392 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Brian RigertDirectorNamed in SEC Form D filings
- CHARLES SILVERExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin YanosExecutive OfficerNamed in SEC Form D filings
- Pavan KambamExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Vaibhav KumarDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 25- PendingSurfactants Having Pefa Compounds And Methods Of Use ThereofUSPTOApplication 18869001
- PendingFoam Control Agents Formed From Polyol Ester Of Fatty Acids (pefas)USPTOApplication 18869009
- PendingCleaning Compositions With Improved Detergent CompoundsUSPTOApplication 63898052
Show all 25 patent records
- Surfactants Having Pefa Compounds And Methods Of Use ThereofDec 4, 2025 · Application 18869001Pending
- Foam Control Agents Formed From Polyol Ester Of Fatty Acids (pefas)Nov 6, 2025 · Application 18869009Pending
- Cleaning Compositions With Improved Detergent CompoundsApplication 63898052Pending
- Cleaning Compositions With Improved Detergent CompoundsApplication 63749656Pending
- Methods For Tuning The Hydrophilic-lipophilic Balance Of Extracellular GlycolipidsApplication PCTUS2024062093Pending
- Compositions With Improved Solubilizing AgentsApplication PCTUS2024061663Pending
- Cleaning Compositions With Improved Detergent CompoundsApplication 63730912Pending
- Emulsifiers Formed From Polyol Esters Of Fatty AcidsApplication 18869027Pending
- Suspensions With Multifunctional Wetting And/or Dispersing AgentsApplication PCTUS2024056408Pending
- Engineered Polyol Lipid Producing MicroorganismsApplication PCTUS2024053978Pending
- Methods For Tuning The Hydrophilic-lipophilic Balance Of Extracellular GlycolipidsApplication 63616181Pending
- Compositions With Improved Solubilizing AgentsApplication 63614366Pending
- Suspensions With Multifunctional Wetting And/or Dispersing AgentsApplication 63600608Pending
- Engineered Polyol Lipid Producing MicroorganismsApplication 63594874Pending
- Surfactants Having Pefa Compounds And Methods Of Use ThereofApplication PCTUS2023067577Pending
- Foam Control Agents Formed From Polyol Ester Of Fatty Acids (pefas)Application PCTUS2023067582Pending
- Emulsifiers Formed From Polyol Esters Of Fatty AcidsApplication PCTUS2023067583Pending
- POLYOL ESTER OF FATTY ACIDS (PEFAs) AS EMULSIFIERSApplication 63365406Pending
- Polyol Ester Of Fatty Acids (pefas) As AntifoamApplication 63365405Pending
- Compounds, Compositions, And Methods Of Use ThereofApplication 63365404Pending
- Suspensions With Multifunctional Wetting And/or Dispersing AgentsApplication 19588156Pending
- Methods For Tuning The Hydrophilic-lipophilic Balance Of Extracellular GlycolipidsApplication 19602518Pending
- Engineered Polyol Lipid Producing MicroorganismsApplication 19583726Pending
- Compositions With Improved Solubilizing AgentsApplication 19599700Pending
- Cleaning Compositions With Improved Detergent CompoundsApplication PCTUS2025059234Pending
Related companies, and why
- CytomX TherapeuticsSimilar federal contract value in Biotech · null in contracts
- POP ART, INC.Similar federal contract value in Biotech · null in contracts
- Dovetail Genomics, LLCSimilar federal contract value in Biotech · null in contracts
- VasaMetrixSimilar federal contract value in Biotech · null in contracts
- SimBioSys, Inc.Similar federal contract value in Biotech · null in contracts
- C4 TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .